drugset / Trial / NCT03922919

Effect of Administration of 3rd Generation Cephalosporin on the Digestive Carrying of 3rd Generation Cephalosporin-resistant Enterobacteriaceae (CEF-IMPACT)

NCT03922919

Phase 4 Unknown 250 enrolled Centre Hospitalier Universitaire de Besancon
Non-randomizedSequentialOpen-labelTreatment

Summary

The aim of this study was to compare the frequency of occurrence of digestive carrying of 3rd generation cephalosporin-resistant enterobacteriaceae (EB C3G-R), acquired during hospitalization in one of the participating departments, between patients treated with ceftriaxone and patients treated with cefotaxime

Timeline

Start
2018-04-03
Primary completion
2020-04-03
Completion
2020-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Cefotaxime Small molecule
Comparator Ceftriaxone Other / unclassified